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研究の概要 
 
1. Introduction 
DNA-PK is involved in DNA DSB repair and V(D)J recombination.  DNA-PK is a 
trimetric enzyme consisting of a 460 kDa catalytic subunit, DNA-PKcs, and a heterodimeric 
regulatory complex called Ku, which is comprised of 70 kDa Ku70 and 86 kDa Ku80 
subunits (1-3).  The three gene products were identified through studies of 
ionizing-radiation-sensitive Chinese hamster cell lines and cells from severe combined 
immunodeficient (SCID) mice (4-8).  The Ku protein is evolutionarily conserved and its 
homologues have been identified in vertebrates, Drosophila, and Saccharomyces cerevisiae 
(9, 10).  The Ku heterodimer serves as a DNA binding component of DNA-PK (1), and is 
capable of both sequence-independent and sequence-specific DNA binding (11, 12).  These 
characteristics implicate DNA-PK in DNA repair or in DNA damage signaling pathways.  In 
addition, recent reports disclosed the involvement of the Ku protein in telomere maintenance, 
transcriptional regulation, lymphocyte development, and tumor suppression (13, 14), 
suggesting that the molecules are multifunctional housekeepers in cells (6-8). 
Expression of transfected human Ku80 gene to Ku80-deficient cells restores 
radiosensitivity, DNA end-binding activity and the ability to support V(D)J recombination (4, 
15, 16).  Ku80 knock-out mice show SCID phenotypes and general growth retardation, 
signifying the roles of Ku protein in V(D)J recombination and DNA repair that may influence 
cell proliferation (17, 18).  Similarly, Ku70 deficiency results in increased ionizing 
radiosensitivity, defective DNA end-binding activity, and the inability to support V(D)J 
recombination in murine embryonic stem cells with targeted disruption of the gene (19) and 
in Ku70-deficient mice (20, 21).  Cells deficient in Ku proteins also show hypersensitivity to 
some kinds of DNA DSB-causing cytotoxic agents (22-25). 
Meanwhile, in the clinical situation, cellular resistance to chemotherapy and/or 
radiotherapy is a significant component of tumor treatment failure.  A variety of factors are 
thought to underline the mechanisms of the resistance (26).  Although certain resistance 
mechanisms might be specific for either chemo- or radioresistance, others might be common 
to both therapeutic modalities.  In particular, the study of DNA repair genes may provide 
promising insight into common resistance mechanisms of these modalities, and overcoming 
the resistance would yield further improvements in the results of cancer treatment. 
  In this study, we employed antisense nucleic acid strategy to achieve partial reduction of 
Ku70 in a human lung cancer cell line.  This suppression of Ku70 resulted in increased 
radiosensitivity and chemosensitivity to some DNA-damaging agents. 
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2. Materials and methods 
2.1. Preparation of Ku70 antisense and sense constructs 
  Human Ku70 cDNA was isolated by PCR amplification of a human cDNA library that was 
prepared from a primary human skin fibroblast culture.  The PCR primers were designed 
based on the previously published data by Reeves et al.(27).  Briefly, a 5'-end of the gene 
(1680 bp in length) was PCR amplified and the product was verified as the human Ku70 
cDNA by a restriction map containing various restriction enzymes (data not shown).  The 
fragment was inserted into pBluescript II SK (Stratagene, La Jolla, CA), and a part of the 
insert, together with a small part of the vector, was re-amplified by PCR.  Then, the 
fragment containing the 525 bp 5'-end of the gene (the corresponding position, from 1 to 525 
bp in reference (27) ) with the initiation codon ATG at position 34 to 36 bp was inserted into 
the pCAGGS plasmid (kindly provided by Professor Miyazaki, J., (28) ) under the control of 
the β-actin promoter.  Thus, sense and antisense constructs of the gene were obtained. 
 
2.2. Cell culture and DNA transfection 
  A human lung squamous cell carcinoma cell line, RERF-LC-AI (Riken Gene Bank, 
#RCB0444, Tsukuba, Japan), was grown as monolayer cultures in a humidified, 5% CO2 
atmosphere with minimum essential medium (GIBCO BRL, Rockville, MD., Catalog # 
11700-077) supplemented with 10% heat-inactivated calf serum.  Each sense and antisense 
Ku70 construct was linearized by Pvu I digestion and was transfected to the cells by calcium 
phosphate co-precipitation method.  A selection plasmid containing the hygromycin resistant 
gene under the control of phosphoglycerate kinase promoter in pBluescript II SK was 
co-transfected.  After 36-hour incubation, 200 µg/ml of hygromycin (Wako Pure Chemical, 
Osaka, Japan) was added to the medium for selection.  Individual colonies were isolated 
after additional seven-day cultures. 
 
2.3. Northern blot analysis 
  Samples consisting of 10 μg of total RNA isolated from subconfluently cultured cells were 
electrophoresed and transferred to membranes.  The 525 bp 5’-end fragment of the Ku70 
cDNA labeled with digoxigenin-11-dUTP was used as a probe. 
 
2.4. Western blot analysis 
  Samples containing 50 μg of total protein extracted from cultured cells were 
electrophoresed on 7.5% SDS-PAGE, and blotted to membranes.  Primary antibodies for 
Ku70, Ku80, DNA-PKcs, and actin were from Santa Cruz Biotechnology Inc. (Santa Cruz, 
CA;  catalog names and numbers:  Ku-70 [C-19]: # sc-1486, Ku-86 [M-20]: # sc-1485, 
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DNA-PKcs [C-19]: # sc-1552, Actin [C-11]: # sc-1615).  The secondary antibody, anti-goat 
IgG-HRP, from the same company was used to visualize the protein expression by an 
enhanced chemiluminescence detection kit (Amersham Biosciences, Buckinghamshire; 
catalog # 25-0062-62) according to the manufacturer’s instructions. 
 
2.5. Electromobility shift assay 
Electromobility shift assay has been performed similar as described earlier (29).  The 
following two oligonucleotides, 
GATTTCCCGCTAGCAATATTCTGCAGCCAAGCTTCCGCGC (forward) and 
GCGCGGAAGCTTGGCTGCAGAATATTGCTAGCGGGAAATC (reverse), were 
denatured and reannealed together by heating at 100℃ for 5 minutes, then cooled at room 
temperature for 15 minutes.  The annealed double-strand DNA was labeled by T4 
polynucleotide kinase at 37℃ for 30min, and labeled DNA was separated from 
unincorporated label by MicroSpin G-25 (Amersham Biosciences, Buckinghamshire; catalog 
# 27-5325-01).  One-picomole thus prepared free probe was incubated with 4-mg nuclear 
protein extract at room temperature for 15 min in 10mM Tris-HCl, pH7.9, 5mM EDTA, 
100mM NaCl, 10mM KCl, then run on 7.5%-polyacrylamide gel.  Autoradiography was 
done and bands of protein-DNA complexes were quantified with Phosphoimager and 
ImageQuant software (Amersham Biosciences, Buckinghamshire). 
 
2.6. Radiosensitivity assay in vitro 
The cells were propagated in vitro and the resulting subconfluent cultures were X-ray 
irradiated at doses ranging from 0 to 12 Gy (approximate dose rate, 38 cGy/min).  They 
were immediately re-plated in triplicate for colonogenic assay.  At day 10 of the irradiation, 
surviving colonies were stained with 1-% crystal violet and were counted with the aid of a 
dissecting microscope.  Three to ten independent experiments were repeated for each clone.  
In each experiment, each survival curve (data not shown) was fitted to the linear-quadratic 
model for cell survival by using Kaleidagraph 3.05, for Macintosh (Synergy Software, 
Reading, PA) to calculate the α, β, and D10 (doses to reduce colonogenecity to 10 %) values 
to make Table 1.  In addition, the mean survival fraction at a certain dose in each clone was 
plotted to draw a survival curve, which was also fitted to the linear quadratic model, to 
represent this clone. 
 
2.7. Chemosensitivity assay in vitro 
After re-plating the subconfluently cultured cells on tissue culture dishes, the cells were 
cultured for an additional six hours to allow them to adhere to the plates.  Then, a cytotoxic 
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agent was added to the culture medium for various periods depending on the agents.  Each 
agent and exposure time were as follows: bleomycin (Nippon Kayaku K. K., Tokyo), 
mitomycin C (Kyowa Hakko Kogyo K. K., Tokyo), methyl methanesulfonate (Sigma-Aldrich 
Japan K. K., Tokyo) for one hour, cisplatin (Bristol-Myers Squibb K. K., Tokyo) for three 
hours, and paclitaxel (Bristol-Myers Squibb K. K., Tokyo) for 24 hours.  After exposure, the 
cells were washed twice with complete medium and incubated for additional 10 days.  
Surviving colonies were stained with 1-% crystal violet and counted as mentioned above.  
Each group consisted of three independent experiments and each experiment was done in 
triplicate.  Each survival curve of each experiment was drawn (data not shown) only for the 
calculation of the D10 values, and the means of the D10 values of the transfectants were 
compared to the parental cells.  The mean survival fraction at a certain dose in each clone 
consisting of three experiments was plotted to draw a survival curve to represent this clone. 
 
2.8. Statistic analysis 
Unpaired Student’s t tests were used for comparison of means of the parameters.  The 
parameters of any transfectant (70S-1, 70S-2, 70AS-1, 70AS-2, and 70AS-3) were compared 
to the corresponding parameters of the parental cells.  Differences in means with p value less 
than 0.05 (two-tailed) were judged as significant. 
 
3. Results 
3.1. Establishment of clones with expression of antisense and sense Ku70 
  After DNA transfection and selection with hygromycin, resulting colonies were propagated 
and tested for the transfected gene expression by Northern blot analysis.  Thus, ten antisense 
and twelve sense transfected clones were isolated.  Among them, two clones (70S-1 and 
70S-2) with sense, and three clones (70AS-1, 70AS-2, and 70AS-3) with antisense constructs 
that showed the highest expression of the genes were selected for further experiments.  In 
spite of the high expression of antisense Ku70 mRNA, the expressions of wild type Ku70 
mRNA were not decreased in those clones in comparison to the parental cells (Fig. 1). 
 
3.2. Protein expression of Ku70, Ku80 and DNA-PKcs 
  Western blot analyses were carried out using each corresponding antibody to Ku70, Ku80 
and DNA-PKcs proteins.  The results disclosed that the Ku70 protein expression was 
significantly suppressed in all of the three clones with antisense Ku70 construct, but not in the 
clones with the sense Ku70 construct, when compared to the expression in the parental cells.  
In contrast, DNA-PKcs protein levels of the three clones with antisense Ku70 were similar to 
the two clones with sense Ku70 and the parental cells.  As to Ku80 protein, the conclusion 
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was not clear because the expression of Ku80 in the samples of 70AS-1 and 70AS-2 seems to 
be slightly reduced while that of 70AS-3 does not seem to be reduced.  Anyway, the 
imbalance in Ku70 and Ku80 expression is still significant (Fig. 2). 
 
3.3. Electromobility shift assay 
Electromobility shift assay of the cells revealed two bands, B1 and B2, in each sample.  
The three clones with antisense Ku70 construct showed reduced B2 compared to the two 
clones with sense Ku70 construct and the parental cells, while all the clones had comparable 
B1 (Fig. 3). 
 
3.4. In vitro radiosensitivity 
  Colonogenic assays after irradiation revealed relatively small but statistically significant 
increases in radiosensitivity of the clones with antisense Ku70 construct when compared to 
the parental cells.  On the other hand, the radiosensitivity of the clones with sense construct 
was similar to the parental cells (Tab. 1 and Fig. 4).  The α values of the cells with antisense 
constructs were significantly higher than those of the parental cells, and the D10 values, the 
surviving fractions at a dose of 2 Gy (SF2Gy) and the ones at a dose of 8 Gy (SF8Gy) of the 
cells with antisense constructs, were significantly smaller than those of the parental cells, 
whereas those parameters of the clones with sense construct were comparable to those of the 
parental cells (Table 1). 
 
3.5. In vitro chemosensitivity 
Figure 5 shows the survival curves of cells treated with the six different cytotoxic agents.  
When compared to the parental cells, the clones with antisense construct showed increased 
chemosensitivity to bleomycin (Fig. 5A) and methyl methanesulfonate (Fig. 5B), but not to 
cisplatin (Fig. 5C), mitomycin C (Fig. 5D), and paclitaxel (Fig. 5E).  These findings were 
supported by statistically comparing D10 value in each cell group (data not shown). 
 
4. Discussion 
The present study demonstrated successful, but partial suppression of Ku70 protein in a 
human lung squamous cell carcinoma cell line by introducing an antisense Ku70 construct to 
the cells, and consequently, the transfected cells showed increased sensitivity to ionizing 
radiation and to some cytotoxic agents including bleomycin and methyl methanesulfonate.  
The results are quite reasonable because radiation and those agents are cytotoxic by causing 
DNA DSB in cells, and Ku70 protein is one of the DNA DSB repair gene products. 
Although murine embryonic stem cells with gene targeted deletion of Ku70 (19) and 
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fibroblasts from Ku70-deficient mice (21) are reportedly sensitive to ionizing radiation, there 
has been no study on a partial reduction of Ku70 expression.  This study achieved a marked 
but still partial reduction of the Ku70 protein and resulted in partial reduction in DNA end 
binding activity by means of antisense nucleic acid strategy.  The molecular mechanisms of 
antisense nucleic acid are thought to involve inhibition of splicing, translational arrest, 
disruption of necessary RNA structure, 5’-capping, and activation of RNaseH (30).  
Although some previous studies demonstrated that the antisense nucleic acid strategies were 
successful in decreasing both mRNA and protein expressions of the target genes, the wild 
type Ku70 mRNA was not reduced in our study.  The antisense construct may bind to the 
transcript and prevent its translation but not actually target it for degradation.  The precise 
reason is not clear, but a situation similar to ours has been observed in other antisense 
experiments (31, 32).   
  Positive correlation between Ku70 and Ku80 expression has been previously reported.  
Ku80-deficient mice exhibit reduced Ku70 expression (17), and Ku70-deficient mice and 
embryonic stem cells exhibit reduced Ku80 expression (19, 21).  In addition, a study on two 
mutant cell lines, XR-V15B and XR-V9B, demonstrated that even mutated Ku80 containing 
partial deletions was responsible for impaired stabilization of Ku70, X-ray resistance and 
V(D)J recombination (33).  The authors of those studies speculated that Ku70/Ku80 
heterodimerization is required for the stability of Ku protein expression; total deletion of 
either component would result in destabilizing the expression of the other component.  In the 
present study, the clones in which the Ku70 protein expression was partially reduced showed 
relatively conserved Ku80 protein expression as compared to the parental cells.  It suggests 
that only a partial expression of Ku70 protein might be enough for stabilizing Ku80 protein, 
although further studies are needed to confirm the phenomenon. 
The survival curves of the clones with antisense Ku70 after irradiation clearly 
demonstrated the increased radiosensitivity of the clones, and this was accompanied by 
increased α and α/β values, indicating a smaller "shoulder" or reduced Dq.  The result 
seemed reasonable because α/β and Dq are related to sublethal damage repair (34, 35). 
As for chemosensitivity, the clones with antisense Ku70 construct demonstrated increased 
sensitivity to bleomycin and methyl methanesulfonate, but not to cisplatin, mitomycin C and 
paclitaxel.  These results could be expected, because bleomycin and methyl 
methanesulfonate are known to cause DNA DSB (22, 36), whereas paclitaxel's toxicity is due 
to its ability of binding to tubulins and provide stabilization of microtubules at the M phase of 
the cell cycle.  On the other hand, there are some controversial reports about the 
relationships between DNA DSB repair and DNA cross-linking agents such as mitomycin C 
(22, 37, 38) and cisplatin (37, 40, 41). 
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  Although cell lines derived from Ku70 knock-out mice are available (19) and their 
radiosensitivity is much greater than that of our Ku70 antisense-expressing human cells, our 
model is still important because of the following reasons; 1) Clinical cancer radiotherapy is 
usually performed in multiple fractions with an ordinary single dose ranging from 1.2 to 2.0 
Gy in most treatment protocols.  In this case, even a small increase in radiosensitivity at a 
low dose would yield significant differences in biological effect (42).  2) The antisense 
approach can be relatively easily applied clinically by using already available gene delivery 
systems. 
We envision that our experimental model could be further applied to investigations of the 
mechanisms of radio- and chemoresistance of cancer cells, as well as to some future gene 
therapies. 
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Table 1  In vitro radiosensitivity of the parental cells and transfectants with 
antisense or sense Ku70 constructs 
 
   Clones    
 Parental 
cells 
70S-1 70S-2 70AS-1 70AS-2 70AS-3 
Parame
ters 
( n = 10 ) ( n = 5 ) ( n = 4 ) ( n = 5 ) ( n = 3 ) ( n = 3 ) 
α 0.300±
0.134 
0.387±
0.200 
0.266±
0.154 
0.644±
0.086 
0.728±
0.273 
0.590±
0.264 
  (0.3318)* (0.6826) (0.0002) (0.0026) (0.0224) 
β 0.031±
0.015 
0.023±
0.020 
0.039±
0.020 
0.028±
0.009 
0.013±
0.028 
0.028±
0.024 
  (0.4203) (0.4222) (0.7623) (0.1781) (0.8376) 
D10 (Gy) 5.1±0.6 4.7±0.9 5.0±0.4 3.1±0.2 3.0±0.8 3.4±0.8 
  (0.3534) (0.8091) (<0.001) (0.004) (0.0015) 
SF2Gy 0.734±
0.175 
0.619±
0.133 
0.611±
0.118 
0.358±
0.122 
0.281±
0.114 
0.327±
0.115 
  (0.2203) (0.2253) (0.0009) (0.0016) (0.0033) 
SF8Gy 0.013±
0.008 
0.013±
0.009 
0.009±
0.002 
0.001±
0.001 
0.002±
0.001 
0.002±
0.002 
  (0.9723) (0.3505) (0.0051) (0.0308) (0.0400) 
 
*  The numbers in parentheses are p values of the differences of the parameter 
values of the columns when compared to that of the parental cells.  All the 
clones with antisense Ku70 constructs, but not clones with sense constructs, 
showed increased radiosensitivity in terms of the parameters α, D10, SF2Gy, and 
SF8Gy. 
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Fig. 1 
Northern blotting using the 5'-end of the Ku70 cDNA probe.  Truncated and transfected 
sense and antisense Ku70 were highly expressed in the transfectants (70S-1 and 70S-2 
represent clones with sense construct; 70AS-1, 70AS-2 and 70AS-3 represent clones with 
antisense construct).  Expression levels of the full-length wild type Ku70 were identical 
among these sense clones, antisense clones, and parental cells, RERF-LC-AI.  Actin 
expression was also examined as an internal control. 
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Fig.2 
Protein expressions of Ku70, Ku80, and DNA-PKcs in the parental and transfected clones.  
The clones with antisense construct showed markedly decreased expression of the Ku70 
protein, compared to the clones with sense construct and parental cells.  No expression 
difference, however, was observed among these clones in respect to Ku80 and DNA-PKcs.  
Actin expression was also examined as an internal control.  Approximate sizes of the 
proteins were estimated by a set of protein size markers (# P7708S, New England BioLabs 
Inc., Beverly, MA). 
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Fig.3 
Electromobility shift assay of the parental cells, clones with sense construct, and clones with 
antisense construct.  Synthesized 40-bp double-strand DNA was labeled by T4 
polynucleotide kinase and incubated with nuclear protein extract to be run on a 
polyacrylamide gel.  The three clones with antisense Ku70 construct showed reduced B2 
compared to the two clones with sense Ku70 construct and the parental cells.  Relative 
volumes of B1 plus B2 were 1.09 in 70S-1, 1.14 in 70S-2, 0.87 in 70AS-1, 0.86 in 70AS-2, 
and 0.82 in 70AS-3, when the parental cells being 1.00. 
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Fig.4 
In vitro survival curves of the parental cells, clones with sense construct, and clones with 
antisense construct after X-ray irradiation.  The clones with antisense Ku70 construct, 
70AS-1, 70AS-2 and 70AS-3, demonstrated small but statistically significant increases in 
sensitivity to radiation compared to the parental cells, whereas the clones with sense construct, 
70S-1 and 70S-2, showed a similar radiosensitivity to the parental cells (see Table 1 for 
statistical analysis).  Each point of the curves represents an average of three to ten 
independent experiments, and each experiment was performed in triplicate.  The dots and 
bars represent means and standard deviations of surviving fractions of each cell group, 
respectively. 
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Fig.5 
Survival curves by colonogenic assay of the clones after exposure to cytotoxic agents.  The 
agents include bleomycin (A), methyl methanesulfonate (B), cisplatin (C), mitomycin C (D), 
and paclitaxel (E).  The clones with antisense Ku70 construct and diminished protein 
expression of the gene, 70AS-1, 70AS-1, and 70AS-3, showed significantly reduced D10 and 
increased sensitivity to bleomycin and methyl methanesulfonate compared to the parental 
cells.  On the other hand, chemosensitivity to cisplatin, mitomycin C, and paclitaxel was 
identical among all of these groups.  The dots and bars represent means and standard 
deviations of three independent experiments, and each experiment was performed in 
triplicate. 
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